A disruption in federal funds has jeopardized HIV testing and outreach in Mississippi, and researchers warn of a resurgence ...

On April 22, the CDC allegedly informed Emory University in Atlanta that its large HIV self-testing program was being ...

In the face of a fear of loss of funds for ending the HIV/AIDS epidemic, activists in New Jersey walked to raise money.

Medical experts who reviewed the case for Newsweek said a routine blood test could have saved the 45-year-old's life.

GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand ...

Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...

The federal government has terminated almost $2.5 billion in health care grants to the state. Almost one-third of the grants, ...

Gilead will pay $202 million to resolve claims that it paid kickbacks to healthcare providers in the form of honoraria, meals ...

People living with HIV are less likely to receive potentially lifesaving cancer treatment if they live in communities with ...

Prevention and treatment campaigns are not adequately targeting the particular needs of the 50+ year age group. Indeed, ...